Monday, November 09, 2020 6:26:20 PM
Overall the PR showed high confidence. IMO.
With 3 arms of this Trial maybe an aggregate of 25 for each arm is the data pool...BUT...But [proved wrong already...
This PR is slanted toward the number of patients needed for the Phase 3 part of this Trial which was proposed at 642 total for 2b/3 combined. Very positive, IMO.
Collecting data from around the world will be strong evidence and probably a logistical challenge.
Also I like the words 'Phase 3 will start Immediately after Phase 2 data '.
I hope strong efforts are working toward full enrolment and complete Phase 2b asap.
Pfizer vaccine may have 50M doses produced in 2021. Already 50M Covid infections Worldwide with 7B population...and raising
FEATURED Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • Jun 14, 2024 2:07 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM